Literature DB >> 22933591

Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review.

Esther L Davis1, Byeongsang Oh, Phyllis N Butow, Barbara A Mullan, Stephen Clarke.   

Abstract

OBJECTIVE: To explore the nondisclosure of complementary and alternative medicine (CAM) use among cancer patients, including reasons for and outcomes from nondisclosure of CAM use, within the context of patient-doctor communication.
METHOD: A systematic review was conducted exploring investigations surrounding the communication of CAM use for patients with cancer published until August 2011.
RESULTS: A total of 21 studies were located, which reported a prevalence of CAM use among patients with cancer ranging between 11% and 95%; of these patients, 20% to 77% did not disclose their CAM use. The main reasons for nondisclosure were the doctor's lack of inquiry; patient's anticipation of the doctor's disapproval, disinterest, or inability to help; and patient's perception that disclosure of CAM use is irrelevant to their conventional care. There is some evidence to suggest that patient-doctor communication about the use of CAM was associated with an enhanced patient-doctor relationship and higher patient satisfaction.
CONCLUSIONS: Although the use of CAM by patients with cancer is high, patients frequently fail to disclose its use to their health professionals for reasons emanating from both sides of the dyadic patient-doctor relationship. Because a substantial proportion of patients with cancer may use CAM and there is potential for herb- or vitamin-drug interactions, further research in patient-doctor communication about CAM is necessary to maintain patient safety and wellbeing. The development of effective interventions to improve the disclosure of CAM use should be an integral part of this future research.

Entities:  

Mesh:

Year:  2012        PMID: 22933591      PMCID: PMC3500370          DOI: 10.1634/theoncologist.2012-0223

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  43 in total

1.  Can doctors respond to patients' increasing interest in complementary and alternative medicine?

Authors:  D K Owen; G Lewith; C R Stephens
Journal:  BMJ       Date:  2001-01-20

Review 2.  Biopharmacologic and herbal therapies for cancer: research update from NCCAM.

Authors:  M A Richardson
Journal:  J Nutr       Date:  2001-11       Impact factor: 4.798

3.  Use of complementary and alternative medicine among men with prostate cancer in a rural setting.

Authors:  Susan Butler; Ashli Owen-Smith; Colleen DiIorio; Michael Goodman; Jonathan Liff; Kyle Steenland
Journal:  J Community Health       Date:  2011-12

Review 4.  Antioxidants in cancer therapy; their actions and interactions with oncologic therapies.

Authors:  D W Lamson; M S Brignall
Journal:  Altern Med Rev       Date:  1999-10

5.  Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions.

Authors:  H Boon; M Stewart; M A Kennard; R Gray; C Sawka; J B Brown; C McWilliam; A Gavin; R A Baron; D Aaron; T Haines-Kamka
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

6.  Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.

Authors:  M A Richardson; T Sanders; J L Palmer; A Greisinger; S E Singletary
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

7.  Complementary and alternative medicine use among colorectal cancer patients in Alberta, Canada.

Authors:  Suzanne C Tough; David W Johnston; Marja J Verhoef; Keith Arthur; Heather Bryant
Journal:  Altern Ther Health Med       Date:  2002 Mar-Apr       Impact factor: 1.305

8.  Use of herbs in women diagnosed with ovarian cancer.

Authors:  C Bethan Powell; S L Dibble; J E Dall'Era; I Cohen
Journal:  Int J Gynecol Cancer       Date:  2002 Mar-Apr       Impact factor: 3.437

9.  Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians.

Authors:  Taka Ashikaga; Kwadwo Bosompra; Patricia O'Brien; Lee Nelson
Journal:  Support Care Cancer       Date:  2002-04-24       Impact factor: 3.603

10.  Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives.

Authors:  Katsuya Tasaki; Gertraud Maskarinec; Dianne M Shumay; Yvonne Tatsumura; Hisako Kakai
Journal:  Psychooncology       Date:  2002 May-Jun       Impact factor: 3.894

View more
  90 in total

1.  Let's Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative Medicine.

Authors:  Laura Tenner; Fay J Hlubocky; Charles D Blanke; Thomas W LeBlanc; Jonathan M Marron; Molly M McGinnis; Rebecca A Spence; Lynne P Taylor
Journal:  J Oncol Pract       Date:  2019-01       Impact factor: 3.840

2.  Integrative oncology.

Authors:  Gustav Dobos; Holger Cramer; Shrikant Anant; Claudia M Witt; Lorenzo Cohen
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-19       Impact factor: 2.629

3.  Identifying Drug Interactions between Enzalutamide and Complementary Alternative Medications in a Patient with Metastatic Prostate Cancer: A Case Report.

Authors:  Thomas Brownlee; Colleen Olson; Michelle Deschamps
Journal:  Can J Hosp Pharm       Date:  2018-08-28

4.  A Multicenter Comparison of Complementary and Alternative Medicine (CAM) Discussions in Oncology Care: The Role of Time, Patient-Centeredness, and Practice Context.

Authors:  Jon Tilburt; Kathleen J Yost; Heinz-Josef Lenz; María Luisa Zúñiga; Thomas O'Byrne; Megan E Branda; Aaron L Leppin; Brittany Kimball; Cara Fernandez; Aminah Jatoi; Amelia Barwise; Ashok Kumbamu; Victor Montori; Barbara A Koenig; Gail Geller; Susan Larson; Debra L Roter
Journal:  Oncologist       Date:  2019-05-17

5.  Exploring Willingness to Participate in Clinical Trials by Ethnicity.

Authors:  Katrina L Pariera; Sheila T Murphy; Jingbo Meng; Margaret L McLaughlin
Journal:  J Racial Ethn Health Disparities       Date:  2016-09-07

6.  Changes in complementary and alternative medicine use across cancer treatment and relationship to stress, mood, and quality of life.

Authors:  Duck-Hee Kang; Traci McArdle; Yeonok Suh
Journal:  J Altern Complement Med       Date:  2014-10-24       Impact factor: 2.579

Review 7.  Polypharmacy in the Geriatric Oncology Population.

Authors:  Lauren R Hersh; Kathryn Beldowski; Emily R Hajjar
Journal:  Curr Oncol Rep       Date:  2017-09-23       Impact factor: 5.075

8.  Complementary and alternative medicine use among patients with thoracic malignancies.

Authors:  Rashmi S Bismark; Hongbin Chen; Grace K Dy; Elizabeth A Gage-Bouchard; Martin C Mahoney
Journal:  Support Care Cancer       Date:  2014-02-21       Impact factor: 3.603

9.  Prevalence of drug-drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk management.

Authors:  Audrey Bellesoeur; Ithar Gataa; Pascaline Boudou-Rouquette; Audrey Thomas-Schoemann; Anne Jouinot; Sarah El Mershati; Anne-Catherine Piketty; Camille Tlemsani; David Balakirouchenane; Anthia Monribot; Michel Vidal; Rui Batista; Sixtine de Percin; Clémentine Villeminey; Jérôme Alexandre; François Goldwasser; Benoit Blanchet
Journal:  Cancer Chemother Pharmacol       Date:  2021-07-24       Impact factor: 3.333

Review 10.  Natural products against cancer angiogenesis.

Authors:  El Bairi Khalid; El-Meghawry El-Kenawy Ayman; Heshu Rahman; Guaadaoui Abdelkarim; Agnieszka Najda
Journal:  Tumour Biol       Date:  2016-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.